Superseded · version 1: GHK-Cu^↗

A copper-binding peptide named in FDA's list of bulk substances under evaluation for non-injectable compounding.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

FDA lists GHK-Cu, except injectable routes, in Category 1 for bulk substances under evaluation. That listing does not establish FDA approval, safety, or effectiveness.^↗

Organizations named in cited records:

U.S. Food and Drug Administration^↗

Sources for this version

1
503A bulk drug substances under evaluation · GHK-Cu except injectable routes · updated May 14, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked July 22, 2026